Tumor cell-derived angiopoietin-like protein ANGPTL2 is a critical driver of metastasis

Motoyoshi Endo, Masahiro Nakano, Tsuyoshi Kadomatsu, Shigetomo Fukuhara, Hiroaki Kuroda, Shuji Mikami, Tai Hato, Jun Aoi, Haruki Horiguchi, Keishi Miyata, Haruki Odagiri, Tetsuro Masuda, Masahiko Harada, Hirotoshi Horio, Tsunekazu Hishima, Hiroaki Nomori, Takaaki Ito, Yutaka Yamamoto, Takashi Minami, Seiji OkadaTakashi Takahashi, Naoki Mochizuki, Hirotaka Iwase, Yuichi Oike

Research output: Contribution to journalArticle

71 Citations (Scopus)

Abstract

Strategies to inhibit metastasis have been mainly unsuccessful in part due to insufficient mechanistic understanding. Here, we report evidence of critical role for the angiopoietin-like protein 2 (ANGPTL2) in metastatic progression. In mice, Angptl2 has been implicated in inflammatory carcinogenesis but it has not been studied in human tumors. In patients with lung cancer, elevated levels of ANGPTL2 expression in tumor cells within the primary tumor were associated with a reduction in the period of disease-free survival after surgical resection. Transcription factors NFATc, ATF2, and c-Jun upregulated in aggressive tumor cells promoted increased Angptl2 expression. Most notably, tumor cell-derived ANGPTL2 increased in vitro motility and invasion in an autocrine/paracrine manner, conferring an aggressive metastatic tumor phenotype. In xenograft mouse models, tumor cell-derived ANGPTL2 accelerated metastasis and shortened survival whereas attenuating ANGPTL2 expression in tumor cells-blunted metastasis and extended survival. Overall, our findings showed that tumor cell-derived ANGPTL2 drives metastasis and provided an initial proof of concept for blockade of its action as a strategy to antagonize the metastatic process.

Original languageEnglish
Pages (from-to)1784-1794
Number of pages11
JournalCancer Research
Volume72
Issue number7
DOIs
Publication statusPublished - 2012 Apr 1

Fingerprint

Angiopoietins
Neoplasm Metastasis
Neoplasms
Proteins
Activating Transcription Factor 2
Survival
Heterografts
Disease-Free Survival
Lung Neoplasms
Carcinogenesis
Phenotype

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Endo, M., Nakano, M., Kadomatsu, T., Fukuhara, S., Kuroda, H., Mikami, S., ... Oike, Y. (2012). Tumor cell-derived angiopoietin-like protein ANGPTL2 is a critical driver of metastasis. Cancer Research, 72(7), 1784-1794. https://doi.org/10.1158/0008-5472.CAN-11-3878

Tumor cell-derived angiopoietin-like protein ANGPTL2 is a critical driver of metastasis. / Endo, Motoyoshi; Nakano, Masahiro; Kadomatsu, Tsuyoshi; Fukuhara, Shigetomo; Kuroda, Hiroaki; Mikami, Shuji; Hato, Tai; Aoi, Jun; Horiguchi, Haruki; Miyata, Keishi; Odagiri, Haruki; Masuda, Tetsuro; Harada, Masahiko; Horio, Hirotoshi; Hishima, Tsunekazu; Nomori, Hiroaki; Ito, Takaaki; Yamamoto, Yutaka; Minami, Takashi; Okada, Seiji; Takahashi, Takashi; Mochizuki, Naoki; Iwase, Hirotaka; Oike, Yuichi.

In: Cancer Research, Vol. 72, No. 7, 01.04.2012, p. 1784-1794.

Research output: Contribution to journalArticle

Endo, M, Nakano, M, Kadomatsu, T, Fukuhara, S, Kuroda, H, Mikami, S, Hato, T, Aoi, J, Horiguchi, H, Miyata, K, Odagiri, H, Masuda, T, Harada, M, Horio, H, Hishima, T, Nomori, H, Ito, T, Yamamoto, Y, Minami, T, Okada, S, Takahashi, T, Mochizuki, N, Iwase, H & Oike, Y 2012, 'Tumor cell-derived angiopoietin-like protein ANGPTL2 is a critical driver of metastasis', Cancer Research, vol. 72, no. 7, pp. 1784-1794. https://doi.org/10.1158/0008-5472.CAN-11-3878
Endo, Motoyoshi ; Nakano, Masahiro ; Kadomatsu, Tsuyoshi ; Fukuhara, Shigetomo ; Kuroda, Hiroaki ; Mikami, Shuji ; Hato, Tai ; Aoi, Jun ; Horiguchi, Haruki ; Miyata, Keishi ; Odagiri, Haruki ; Masuda, Tetsuro ; Harada, Masahiko ; Horio, Hirotoshi ; Hishima, Tsunekazu ; Nomori, Hiroaki ; Ito, Takaaki ; Yamamoto, Yutaka ; Minami, Takashi ; Okada, Seiji ; Takahashi, Takashi ; Mochizuki, Naoki ; Iwase, Hirotaka ; Oike, Yuichi. / Tumor cell-derived angiopoietin-like protein ANGPTL2 is a critical driver of metastasis. In: Cancer Research. 2012 ; Vol. 72, No. 7. pp. 1784-1794.
@article{d0e00162415a4687a905d7aa353d5c4f,
title = "Tumor cell-derived angiopoietin-like protein ANGPTL2 is a critical driver of metastasis",
abstract = "Strategies to inhibit metastasis have been mainly unsuccessful in part due to insufficient mechanistic understanding. Here, we report evidence of critical role for the angiopoietin-like protein 2 (ANGPTL2) in metastatic progression. In mice, Angptl2 has been implicated in inflammatory carcinogenesis but it has not been studied in human tumors. In patients with lung cancer, elevated levels of ANGPTL2 expression in tumor cells within the primary tumor were associated with a reduction in the period of disease-free survival after surgical resection. Transcription factors NFATc, ATF2, and c-Jun upregulated in aggressive tumor cells promoted increased Angptl2 expression. Most notably, tumor cell-derived ANGPTL2 increased in vitro motility and invasion in an autocrine/paracrine manner, conferring an aggressive metastatic tumor phenotype. In xenograft mouse models, tumor cell-derived ANGPTL2 accelerated metastasis and shortened survival whereas attenuating ANGPTL2 expression in tumor cells-blunted metastasis and extended survival. Overall, our findings showed that tumor cell-derived ANGPTL2 drives metastasis and provided an initial proof of concept for blockade of its action as a strategy to antagonize the metastatic process.",
author = "Motoyoshi Endo and Masahiro Nakano and Tsuyoshi Kadomatsu and Shigetomo Fukuhara and Hiroaki Kuroda and Shuji Mikami and Tai Hato and Jun Aoi and Haruki Horiguchi and Keishi Miyata and Haruki Odagiri and Tetsuro Masuda and Masahiko Harada and Hirotoshi Horio and Tsunekazu Hishima and Hiroaki Nomori and Takaaki Ito and Yutaka Yamamoto and Takashi Minami and Seiji Okada and Takashi Takahashi and Naoki Mochizuki and Hirotaka Iwase and Yuichi Oike",
year = "2012",
month = "4",
day = "1",
doi = "10.1158/0008-5472.CAN-11-3878",
language = "English",
volume = "72",
pages = "1784--1794",
journal = "Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "7",

}

TY - JOUR

T1 - Tumor cell-derived angiopoietin-like protein ANGPTL2 is a critical driver of metastasis

AU - Endo, Motoyoshi

AU - Nakano, Masahiro

AU - Kadomatsu, Tsuyoshi

AU - Fukuhara, Shigetomo

AU - Kuroda, Hiroaki

AU - Mikami, Shuji

AU - Hato, Tai

AU - Aoi, Jun

AU - Horiguchi, Haruki

AU - Miyata, Keishi

AU - Odagiri, Haruki

AU - Masuda, Tetsuro

AU - Harada, Masahiko

AU - Horio, Hirotoshi

AU - Hishima, Tsunekazu

AU - Nomori, Hiroaki

AU - Ito, Takaaki

AU - Yamamoto, Yutaka

AU - Minami, Takashi

AU - Okada, Seiji

AU - Takahashi, Takashi

AU - Mochizuki, Naoki

AU - Iwase, Hirotaka

AU - Oike, Yuichi

PY - 2012/4/1

Y1 - 2012/4/1

N2 - Strategies to inhibit metastasis have been mainly unsuccessful in part due to insufficient mechanistic understanding. Here, we report evidence of critical role for the angiopoietin-like protein 2 (ANGPTL2) in metastatic progression. In mice, Angptl2 has been implicated in inflammatory carcinogenesis but it has not been studied in human tumors. In patients with lung cancer, elevated levels of ANGPTL2 expression in tumor cells within the primary tumor were associated with a reduction in the period of disease-free survival after surgical resection. Transcription factors NFATc, ATF2, and c-Jun upregulated in aggressive tumor cells promoted increased Angptl2 expression. Most notably, tumor cell-derived ANGPTL2 increased in vitro motility and invasion in an autocrine/paracrine manner, conferring an aggressive metastatic tumor phenotype. In xenograft mouse models, tumor cell-derived ANGPTL2 accelerated metastasis and shortened survival whereas attenuating ANGPTL2 expression in tumor cells-blunted metastasis and extended survival. Overall, our findings showed that tumor cell-derived ANGPTL2 drives metastasis and provided an initial proof of concept for blockade of its action as a strategy to antagonize the metastatic process.

AB - Strategies to inhibit metastasis have been mainly unsuccessful in part due to insufficient mechanistic understanding. Here, we report evidence of critical role for the angiopoietin-like protein 2 (ANGPTL2) in metastatic progression. In mice, Angptl2 has been implicated in inflammatory carcinogenesis but it has not been studied in human tumors. In patients with lung cancer, elevated levels of ANGPTL2 expression in tumor cells within the primary tumor were associated with a reduction in the period of disease-free survival after surgical resection. Transcription factors NFATc, ATF2, and c-Jun upregulated in aggressive tumor cells promoted increased Angptl2 expression. Most notably, tumor cell-derived ANGPTL2 increased in vitro motility and invasion in an autocrine/paracrine manner, conferring an aggressive metastatic tumor phenotype. In xenograft mouse models, tumor cell-derived ANGPTL2 accelerated metastasis and shortened survival whereas attenuating ANGPTL2 expression in tumor cells-blunted metastasis and extended survival. Overall, our findings showed that tumor cell-derived ANGPTL2 drives metastasis and provided an initial proof of concept for blockade of its action as a strategy to antagonize the metastatic process.

UR - http://www.scopus.com/inward/record.url?scp=84859377402&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859377402&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-11-3878

DO - 10.1158/0008-5472.CAN-11-3878

M3 - Article

C2 - 22345152

AN - SCOPUS:84859377402

VL - 72

SP - 1784

EP - 1794

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 7

ER -